Sinopharm
1099.HK
#2853
Rank
C$8.35 B
Marketcap
C$2.68
Share price
-1.69%
Change (1 day)
-20.37%
Change (1 year)
The Sinopharm Group is a Chinese pharmaceutical company that researches, develops, produces, sells and markets pharmaceuticals and other health products.

Earnings for Sinopharm (1099.HK)

Earnings in 2025: C$3.40 Billion

According to Sinopharm's latest financial reports the company's current earnings are C$82.21 Billion. In 2025 the company made an earning of C$3.40 Billion, an increase over its 2024 earnings that were of C$3.18 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for Sinopharm from 2006 to 2025

Annual earnings

Year Earnings Change
2025C$3.40 B6.59%
2024C$3.18 B-27.86%
2023C$4.42 B-0.73%
2022C$4.45 B-1.72%
2021C$4.53 B11.7%
2020C$4.05 B18.44%
2019C$3.42 B10.85%
2018C$3.09 B3.05%
2017C$2.99 B36.48%
2016C$2.19 B7.11%
2015C$2.05 B12.38%
2014C$1.82 B25.05%
2013C$1.45 B22.54%
2012C$1.19 B35.43%
2011C$0.87 B52.24%
2010C$0.57 B30.99%
2009C$0.44 B60.59%
2008C$0.27 B48.29%
2007C$0.18 B123.29%
2006C$82.95 M